Butrint Aliu

Experience

1. Pureos BioventuresAssociatecurrent2025 — present
2. Pureos BioventuresAnalyst2023 — 2025
3. Tavo BiotherapeuticsBoard Observercurrent2026 — present
4. Evidence Bio SASBoard Observercurrent2025 — present
5. AnaCardioBoard Observercurrent2025 — present
6. Araris Biotech AGBoard Observercurrent2024 — present
7. Memo Therapeutics AGBoard Observercurrent2023 — present
8. University of BaselProject Leader2021 — 2023
9. Polyneuron Pharmaceuticals AGDrug Discovery & Development Lead2017 — 2021

Education

1. University of BaselPhD, Pharmaceutical Sciences

Skills & more

From Butrint's professional profile.

Same school

Also attended University of Basel14

CUChristina UlardicPartner at Astanor VenturesMGMarkus GemuendSenior Advisor at Adjuvant CapitalNKNadine KuglerHead of Tech Communications at QAI VenturesDODavide OttoliniCo-founder at Korify CapitalRLRobin LauberInvestor at Korify CapitalFBFlorian BitterliInvestor at DeepTech Ventures

+ 8 more

Shared employers

Also worked at Pureos Bioventures10

KBKlaus BreinerManaging Partner at Pureos BioventuresDEDominik EscherManaging Partner at Pureos BioventuresMMMartin MünchbachManaging Partner at Pureos BioventuresXDXiming DingInvestment Manager at Pureos BioventuresAGAnne GrahlAssociate at Pureos BioventuresVGVeronica Gambillara FonckPartner at Pureos Bioventures

+ 4 more

Also worked at Tavo Biotherapeutics2

DEDominik EscherManaging Partner at Pureos BioventuresDBDaniel BradburyInvestor at BioBrit

Also worked at Evidence Bio SAS2

HBHadrien BouchezPartner at Kurma PartnersFDFlorence de CoorebyterAssociate at Kurma Partners

Also worked at Araris Biotech AG9

DKDima KuzminManaging Partner at 4BIO CapitalTLTherese LiechtensteinPartner at 4BIO CapitalBMBrian McVeighVenture Partner, USA at 4BIO CapitalMSMichael SidlerFounding Partner at redalpineDKDmitry KuzminManaging Partner at 4BIO CapitalDEDominik EscherManaging Partner at Pureos Bioventures

+ 3 more